Fundraising Fox

Story Ventures2025 Investments

4 investments dated 2025 · listed companies and verified rows first · show all

Delfinadelfina.comin𝕏Feb 2025 · $17M

Delfina provides a pregnancy support app, including a "Delfina Doula" feature, that lets pregnant people share symptoms and health data such as blood pressure with their providers between appointments.

Digital HealthFemTechHealthtech

Co-investorsArtis VenturesBread And Butter Ventures, LlcSemperVirens Venture CapitalUS Venture PartnersMetrodora VenturesTokio Marine Future Fund

Delfina CareJan 2025 · $17M

HealthtechSan Francisco, US

Senan Ebrahim(Executive Officer, Director)Isabel Fulcher(Director)

BoardDafina Toncheva(Director)inJacob Yormak(Director)

Co-investorsBoutique Venture PartnersArtis VenturesBread And Butter Ventures, LlcBread Butter VenturesGoodwater CapitalMetrodora Ventures+3 more

Inspireninspiren.cominSep 2025 · $100M

Inspiren offers Emergency Call (eCall), a connected emergency response system for senior living communities that combines two-way voice, visual context, and AI-powered condition monitoring with support from nurses and clinical experts.

AI & Machine LearningDigital HealthHealthtech

Michael Wang(Founder & Chief Clinical Officer)inDominique Simoneau-Ritchie(Chief Technology Officer)Stephanie Sudbury(Chief Commercial Officer)Jacky Susskind(Chief of Staff)Lynne Hamilton(Chief People Officer)

Co-investorsAvenir Growth CapitalInsight PartnersPrimary Venture PartnersScale Venture PartnersThird PrimeAvenir+1 more

Veylanveylan.comAug 2025

Veylan is a marketing operations platform that unifies campaign work across paid, social, content, and CRM channels in one workspace, using agents and governed workflows to plan, create, activate, and analyze campaigns.

AI & Machine LearningMarketing TechSaaSHuntington, US

Dirk Shaw(Executive Officer, Director)Anthony Iacovone(Executive Officer, Director, Promoter)Daniel Meehan(Executive Officer, Director, Promoter)

BoardEnrique Nagle(Director)

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.